Technical Analysis for SDGR - Schrodinger, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 95.7 | 1.15% | 1.09 |
SDGR closed up 1.15 percent on Friday, January 22, 2021, on 50 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Historical SDGR trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Bearish Engulfing | Bearish | 1.15% | |
Slingshot Bullish | Bullish Swing Setup | 1.15% | |
Upper Bollinger Band Walk | Strength | 1.15% | |
Outside Day | Range Expansion | 1.15% | |
Overbought Stochastic | Strength | 1.15% | |
Upper Bollinger Band Touch | Strength | 1.15% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Up 1% | about 20 hours ago | |
60 Minute Opening Range Breakout | about 22 hours ago | |
Down 1% | about 24 hours ago | |
Outside Day | 2 days ago | |
Down 3% | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2020
Schrödinger, Inc. provides chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. Schrödinger was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in August 1990 and is headquartered in New York, NY.
Sector: Healthcare
Industry: Health Information Services
Keywords: Pharmaceutical Industry Software Solutions Drug Discovery Materials Science Simulation Software Pre Clinical Development
Classification
Sector: Healthcare
Industry: Health Information Services
Keywords: Pharmaceutical Industry Software Solutions Drug Discovery Materials Science Simulation Software Pre Clinical Development
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 99.5 |
52 Week Low | 25.5 |
Average Volume | 991,249 |
200-Day Moving Average | 65.72 |
50-Day Moving Average | 74.70 |
20-Day Moving Average | 86.87 |
10-Day Moving Average | 91.94 |
Average True Range | 4.43 |
ADX | 39.21 |
+DI | 27.15 |
-DI | 8.79 |
Chandelier Exit (Long, 3 ATRs ) | 85.21 |
Chandelier Exit (Short, 3 ATRs ) | 88.99 |
Upper Bollinger Band | 98.35 |
Lower Bollinger Band | 75.40 |
Percent B (%b) | 0.88 |
BandWidth | 26.41 |
MACD Line | 5.85 |
MACD Signal Line | 5.47 |
MACD Histogram | 0.386 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 99.29 | ||||
Resistance 3 (R3) | 98.92 | 97.35 | 98.69 | ||
Resistance 2 (R2) | 97.35 | 96.44 | 97.54 | 98.49 | |
Resistance 1 (R1) | 96.53 | 95.88 | 96.94 | 96.90 | 98.29 |
Pivot Point | 94.96 | 94.96 | 95.17 | 95.15 | 94.96 |
Support 1 (S1) | 94.14 | 94.05 | 94.55 | 94.51 | 93.11 |
Support 2 (S2) | 92.57 | 93.49 | 92.76 | 92.91 | |
Support 3 (S3) | 91.75 | 92.57 | 92.71 | ||
Support 4 (S4) | 92.12 |